Lenacapavir shows 96% HIV prevention success

Lenacapavir shows 96% HIV prevention success

A six-monthly HIV prevention injection containing lenacapavir has been confirmed effective in two pivotal studies. The first study, PURPOSE 1, showed no HIV infections among two-thousand-134 participants, while the second, PURPOSE 2, reported two infections among two-thousand-179 participants. This translates to a 96-percent reduction in HIV infections compared to background incidence. Gilead Sciences plans to file for regulatory approval to market lenacapavir for prevention. Separately, during a press briefing on Monday, the U.S. Department […]

October 15, 2024 42

Oshiwambo

Owenda yoshingangamithi sho lenacapavir otayi vulu oku keelela o HIV

Owenda yoku keelela o HIV yoomwedhi 6 yina o lenacapavir oya kolekwa tayi longo ,momalolelo gopaali ga simana. Omapekapeko gotango,go Purpose1 oguulike pwaahena iipotha yo HIV maakuthimbinga 2 134,omanga omatiyali go PURPOSE 2,ga lopota iipotha 2 maakuthimbinga 2 179. Shika osha kalelapo eshonopeko lyoo % 96 lyiipotha yo HIV ,okuyeleka kiiniingwanima ya tetekele. O Gilead Sciences oya thaneka oku konga eziminino okuyela o lenacapavir oku keelela o HIV.

October 15, 2024 29

World

HIV breakthrough: drug trial shows injection twice a year is 100% effective against infection

By Linda-Gail Bekker, University of Cape Town A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or […]

July 3, 2024 34

Health / Medical

Pharma firm urged to share new ‘game-changer’ HIV drug

By Daniel Lawler Paris, May 30, 2024 (AFP) - More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease. The drug lenacapavir could be a "real game-changer" in the fight against […]

May 30, 2024 54